Log in to save to my catalogue

The genetics of the p53 pathway, apoptosis and cancer therapy

The genetics of the p53 pathway, apoptosis and cancer therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69848413

The genetics of the p53 pathway, apoptosis and cancer therapy

About this item

Full title

The genetics of the p53 pathway, apoptosis and cancer therapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2008-12, Vol.7 (12), p.979-987

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The p53 tumour suppressor pathway is an attractive target for the development of anticancer therapies. This Perspective highlights recent progress with agents that modulate components of the p53 pathway — in particular, p53 itself and its negative regulator MDM2 — focusing on how studies of their genetic variations, including mutations in cancer ce...

Alternative Titles

Full title

The genetics of the p53 pathway, apoptosis and cancer therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_69848413

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69848413

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/nrd2656

How to access this item